AVI BioPharma said this week that it has appointed K. Michael Forrest to its board of directors. Forrest, who is filling the unexpired term of former director Raymond Ruddon, will serve until 2006. Rudden is transitioning to the company’s scientific advisory board.
Forrest was previously CEO of Cellegy Pharmaceuticals. Prior to this, he served in various positions at American Cyanimid and Pfizer.